How Quickly Does Valtrex Work for Cold Sores?

Valtrex (valacyclovir) starts working within hours of your first dose, but visible results take a bit longer. In clinical trials, people who took Valtrex saw pain and discomfort resolve in a median of 1.2 to 1.5 days, roughly half a day faster than those who took a placebo. The total healing time is shortened by about half a day to just under a day compared to letting a cold sore run its course on its own.

What Happens After You Take It

Once you swallow Valtrex, your body converts it into its active form, which gets absorbed into cells infected by the herpes simplex virus. There, it blocks the enzyme the virus needs to copy its DNA. Without that enzyme, the virus can’t replicate, so the outbreak stalls rather than building momentum. This doesn’t kill virus already present, but it stops new copies from being made, giving your immune system a much smaller job to do.

This process begins quickly at the cellular level, but you won’t feel the effects immediately. Most people notice pain starting to fade within the first day or so. In two large placebo-controlled trials, the median time to pain relief was 1.2 days in one study and 1.5 days in the other, compared to 1.8 and 2.2 days for placebo. That half-day advantage may sound modest on paper, but when you’re dealing with a painful, visible sore on your lip, even hours matter.

The Full Healing Timeline

Cold sores typically go through a predictable sequence: tingling, blistering, ulceration, crusting, and healing. Without treatment, the whole process usually takes 7 to 10 days. Valtrex compresses that timeline, shaving off roughly 0.5 to 0.8 days of total healing time in clinical trials. In some cases, especially when taken very early, it can prevent the sore from fully forming at all.

Here’s a rough day-by-day picture of what to expect when you start Valtrex at the first sign of tingling:

  • Hours 0 to 12: The drug is being absorbed and actively blocking viral replication. You may not see visible changes yet, but the outbreak is being contained at the cellular level.
  • Day 1 to 2: Pain, burning, and itching typically begin to ease. If a blister has formed, it may still progress to crusting, but it’s likely to be smaller than it would have been untreated.
  • Day 3 to 5: Crusting and early healing. The sore is drying out and your skin is starting to repair.
  • Day 5 to 7: Most people see full or near-full healing, compared to 7 to 10 days without treatment.

Why Timing Makes Such a Big Difference

Valtrex works by stopping the virus from multiplying. That means it’s far more effective when the virus is still in its early replication phase than after it has already produced millions of copies and triggered a full-blown blister. The CDC recommends starting treatment within one day of symptom onset, or ideally during the prodrome, that tingling, itching, or burning sensation you feel before a sore appears.

If you wait until a blister has already formed and opened, Valtrex will still help, but the benefit shrinks considerably. The virus has already done most of its damage at that point, and the remaining healing is largely your immune system cleaning up. This is why many doctors write a prescription you can keep on hand, so you can start taking it the moment you feel that first warning tingle rather than waiting for an appointment.

How It’s Taken for Cold Sores

The FDA-approved dosing for cold sores is a short, aggressive course: two grams taken twice in one day, spaced 12 hours apart. That’s it. Unlike some antiviral regimens that stretch over five or seven days, cold sore treatment with Valtrex is a single day of medication. You take the first dose as soon as symptoms begin and the second dose about 12 hours later.

Clinical trials tested both a one-day and a two-day regimen and found no meaningful advantage to extending treatment to two days. The one-day course performed just as well, which makes the treatment simple and easy to complete.

How It Compares to Over-the-Counter Options

The main over-the-counter alternative is docosanol (sold as Abreva), a topical cream that works by a different mechanism. Topical options like docosanol, along with prescription topical antivirals, also reduce healing time and pain duration, but typically by less than a day and require multiple applications daily over several days. Valtrex achieves a similar or slightly better result with just two pills in one day.

No head-to-head trials have directly compared Valtrex to over-the-counter treatments. Based on the separate trial data available, both categories offer modest but real improvements over doing nothing. The practical advantage of Valtrex is convenience: two doses versus applying a cream five times a day for four to five days.

Side Effects to Expect

Most people tolerate Valtrex well, especially at the short one-day dosing used for cold sores. The most commonly reported side effect in cold sore trials was headache, occurring in about 14% of adults taking Valtrex compared to 10% on placebo. Dizziness was reported by about 2%. In adolescents aged 12 to 17, headache (17%) and nausea (8%) were the most frequent complaints.

Because the treatment course is so short, side effects tend to be brief and mild. Serious reactions are rare with this dosing schedule. People with kidney problems may need adjusted dosing, since the drug is cleared through the kidneys.

What Valtrex Can and Can’t Do

Valtrex does not cure herpes simplex virus. The virus stays dormant in nerve cells between outbreaks, and no current treatment can eliminate it. What Valtrex does is limit the severity and duration of individual outbreaks by stopping the virus from replicating during an active flare.

For people who get frequent cold sores, daily suppressive therapy with a lower dose of valacyclovir is an option. While the clinical data on viral shedding reduction comes primarily from genital herpes studies (showing a 78% reduction in viral shedding), the same antiviral mechanism applies to the oral herpes virus. Daily suppressive use can reduce both the frequency of outbreaks and the amount of virus present on the skin between outbreaks.